Evidence map›Paper›PMID 29858569›Full record

ArticleNature communications2018

On the role of STAT1 and STAT6 ADP-ribosylation in the regulation of macrophage activation.

Andreas Begitt, James Cavey, Mathias Droescher, Uwe Vinkemeier

Open access · goldAbstract readLetterComment
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. IFN-Induced PARPs-Sensors of Foreign Nucleic Acids?Pathogens (Basel, Switzerland) · 2023
    Review
  6. ADP-Ribosylation in Antiviral Innate Immune Response.Pathogens (Basel, Switzerland) · 2023
    Review
  7. Review
  8. Intracellular mono-ADP-ribosyltransferases at the host-virus interphase.Cellular and molecular life sciences : CMLS · 2022
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Forced Self-Modification Assays as a Strategy to Screen MonoPARP Enzymes.SLAS discovery : advancing life sciences R & D · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Andreas BegittDivision of Infections, Immunity and Microbes, School of Life Sciences, University of Nottingham, Nottingham, NG7 2UH, UK.
James CaveyDivision of Infections, Immunity and Microbes, School of Life Sciences, University of Nottingham, Nottingham, NG7 2UH, UK.
Mathias DroescherDivision of Infections, Immunity and Microbes, School of Life Sciences, University of Nottingham, Nottingham, NG7 2UH, UK.
Uwe VinkemeierDivision of Infections, Immunity and Microbes, School of Life Sciences, University of Nottingham, Nottingham, NG7 2UH, UK. uwe.vinkemeier@nottingham.ac.uk.ORCID 0000-0001-6924-1783
University of Nottingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ADP-RibosylationMacrophage Activation

Identifiers

PMID29858569
PMCPMC5984628
OpenAlexW2807114165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.